{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:49:29Z","timestamp":1789422569336,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.crohns.2011.07.013","type":"journal-article","created":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T13:32:59Z","timestamp":1314711179000},"page":"160-173","source":"Crossref","is-referenced-by-count":118,"title":["Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease"],"prefix":"10.1093","volume":"6","author":[{"given":"Mamoru","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen G.","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Shamsul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Camez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2011.07.013_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000273784","article-title":"Malignancy in Crohn's disease: incidence and clinical characteristics in Japan","volume":"81","author":"Mizushima","year":"2010","journal-title":"Digestion"},{"key":"10.1016\/j.crohns.2011.07.013_bb0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1440-1746.2001.02507.x","article-title":"Efficacy of treatment with chimeric monoclonal antibody (infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings","volume":"16","author":"Asakura","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0015","series-title":"Prescribing information","author":"HUMIRA","year":"2009"},{"key":"10.1016\/j.crohns.2011.07.013_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2011.07.013_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.crohns.2011.07.013_bb0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrgastro.2009.39","article-title":"Crohn's disease: adalimumab improves quality of life","volume":"6","author":"Papadakis","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0035","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1572-0241.2008.02175.x","article-title":"Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial","volume":"103","author":"Loftus","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2009.04088.x","article-title":"Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas","volume":"30","author":"Ng","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2011.07.013_bb0045","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ajg.2009.59","article-title":"Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial","volume":"104","author":"Colombel","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0050","first-page":"868","article-title":"The Journal of the Japanese Society of Internal Medicine","volume":"89","author":"Sugiyama","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.crohns.2011.07.013_bb0055","first-page":"1","article-title":"The O.M.G.E. multinational inflammatory bowel disease survey 1976\u20131982: a further report on 2657 cases","volume":"18","author":"Myren","year":"1983","journal-title":"Scan J Gastro"},{"key":"10.1016\/j.crohns.2011.07.013_bb0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0895-4356(98)00096-1","article-title":"Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00535-003-1220-x","article-title":"Reliability, validity, and responsiveness of the Japanese version of the Inflammatory Bowel Disease Questionnaire","volume":"38","author":"Hashimoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0075","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0149-2918(03)80164-9","article-title":"Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study","volume":"25","author":"Weisman","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.crohns.2011.07.013_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2011.07.013_bb0085","article-title":"Dosage adjustment during long-term adalimumab treatment for Crohn's disease: clinical efficacy and pharmacoeconomics","author":"Sandborn","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.07.013_bb0095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2011.07.013_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10165-008-0045-0","article-title":"Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study","volume":"18","author":"Miyasaka","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.crohns.2011.07.013_bb0105","first-page":"40","article-title":"Allotypic markers","volume":"19","author":"Van Loghem","year":"1986","journal-title":"Monogr Allergy"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/6\/2\/160\/1241091\/6-2-160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T22:27:05Z","timestamp":1503440825000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2011.07.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1873994611002017"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2011.07.013","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}